Leveraging unique technology for creating novel microalgae strains from the environment, we provide microalgae strains useful for industrial and academic applications. Additionally, we offer; 1: consultation on microalgae business plans and experimental designs, 2: guidance on microalgae cultivation techniques, and 3: evaluation of microalgae strains based on growth rate and produced substances. We collaborate with diverse companies—spanning aquaculture, food, semiconductors, chemical materials, pet supplies, and rare metal recovery—as well as universities and research institutions to create new industries that address global challenges.
A startup using regenerative medicine technologies to produce and supply homogeneous, high-precision blood cells at scale. It streamlines infectious disease research and the evaluation of pharmaceuticals and functional materials for efficacy and safety, while also providing research cells, testing cells, and diagnostic kits.
A biotech startup developing T-cell and NK-cell therapies derived from low-immunogenicity iPS cells. It aims to provide new treatments for solid tumors and autoimmune diseases, contributing to the treatment of previously difficult-to-treat intractable diseases.
Utilizing the unique genome editing technology CRISPR-Cas3, C4U develops industrial applications to combat diseases that currently have no effective treatments.
A startup combining genome editing with smart land-based aquaculture to breed and produce high-value fish species using local resources. It aims to revitalize the fisheries industry and stabilize food supply, while contributing to lower environmental impact and regional revitalization.
